172 participants
A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-25
- Start Date:
- 2025-08-27
- Completion:
- 2027-06-30
Conditions
- Chronic Hepatitis D Infection
Interventions
- DRUG
No Results Yet